Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

    Data Compilation
    #PharmaFlow

    Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

    Stock Recap
    #PipelineProspector

    Menu

    Canagliflozin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,753Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    08/04/2025 Alembic Pharmaceuticals Limited
    India
    		 Klasia Co., Ltd. No. 758-16-ND Canagliflozin 2024-10-15 Alembic Pharmaceutical limited Unit-III India API Unit-III, Survey No.: 842, 843, Village - Karakhadi, Taluka - Padra, Dist. Vadodara-391 450, Gujarat, India.
    08/04/2025 Alembic Pharmaceuticals Limited
    India
    		 Darim Biotech Co., Ltd. No. 758-16-ND(1) Canagliflozin 2025-03-11 Alembic Pharmaceutical limited Unit-III India API Unit-III, Survey No.: 842, 843, Village - Karakhadi, Taluka - Padra, Dist. Vadodara-391 450, Gujarat, India.